Shashank K R on The Use of Lumbrokinase from Eudrilus eugeniae
Shashank K R, Assistant Lecturer at Yuvaraja’s College, shared on LinkedIn:
”Cardiovascular diseases driven by thrombosis remain a major global health challenge.
Our study focuses on the isolation, purification, and biochemical characterization of lumbrikinase from Eudrilus eugeniae, demonstrating strong fibrinolytic activity, favorable kinetics, and stability under physiological conditions—highlighting its potential as a safer and effective thrombolytic agent for cardiovascular therapeutics.”
Read the full article here.
Article: Exploring the Fibrinolytic and Biochemical characteristics of Lumbrokinase enzyme from Eudrilus eugeniae for Therapeutic Use
Authors: Shashank K R, Malliah Mahadevaswamy
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 2, 2026, 12:53José Antonio García Erce: The National Transplant Organization Published the 2024 Report of the Global Observatory on Donation and Transplantation
-
Jan 2, 2026, 12:48Reza Shojaei: Stepping into 2026 – Your Daily Commitment Saves Lives
-
Jan 2, 2026, 09:20Rehan Khan Explores Clopidogrel
-
Jan 2, 2026, 09:06Gokhan Ozdemir on Thrombophilia in Young Ischemic Stroke
-
Jan 2, 2026, 08:47Raza Ur Rehman on Fitusiran as a First-in-Class RNAi Therapy in Hemophilia A and B
-
Jan 2, 2026, 03:52Abdul Mannan: When Gender Bias Becomes a Diagnostic Error – Inherited Bleeding Disorders are Still Being Missed
-
Jan 2, 2026, 03:51Samwel Mikaye: Thrombocytopenia in Pregnancy
-
Jan 2, 2026, 03:50Marc Carrier: Clinicians Working With Cancer Patients on DOACs. We Need Your Expertise!
-
Jan 2, 2026, 03:50Emicizumab in Infants: Not Just Cost-effective but Mandatory